Literature DB >> 31542395

Early-onset Parkinsonian behaviors in female Pink1-/- rats.

Julia M Marquis1, Samantha E Lettenberger2, Cynthia A Kelm-Nelson3.   

Abstract

Parkinson disease (PD) is a progressive, neurological disease that affects millions of individuals worldwide. Although instability, rigidity, tremor, and bradykinesia are considered hallmark motor signs of the disease, these are not apparent until mid-to-late stage. In addition to limb motor impairment, individuals with PD also exhibit early-onset speech dysfunction and reduced vocal intelligibility as well as anhedonia and anxiety. Many of these clinical signs vary according to sex in humans with PD. In this study, a translational genetic rat model of early-onset PD (Pink1-/-) was used to address significant gaps in knowledge concerning sex-specific characteristics of limb sensorimotor deficits, vocal motor dysfunction, and changes in affective state. Traditional behavioral tests of limb function, ultrasonic vocalization, anxiety, and anhedonia in the Pink1-/- female rat and wildtype controls were used to test the hypothesis that behavioral performance would significantly differ between genotypes, and that these differences would increase with disease progression (age of the rat). Results demonstrate that Pink1-/- female rats do not exhibit limb sensorimotor deficits but do have significantly reduced intensity (loudness) of vocalizations, and present with anhedonia and anxiety by 8 months of age. Consistent with an early-disease model, Pink1-/- female rats do not exhibit significant decreases in nigrostriatal catecholamines/metabolites, as measured by HPLC. These results are significant in expanding knowledge of early-onset deficits in the female Pink1-/- genetic rat model of PD.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Catecholamine; Estrous; Parkinson disease; Pink1; Rat; Ultrasonic vocalization

Mesh:

Substances:

Year:  2019        PMID: 31542395      PMCID: PMC6824965          DOI: 10.1016/j.bbr.2019.112175

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  69 in total

Review 1.  Animal models of nociception.

Authors:  D Le Bars; M Gozariu; S W Cadden
Journal:  Pharmacol Rev       Date:  2001-12       Impact factor: 25.468

Review 2.  Gender differences in Parkinson's disease: clinical characteristics and cognition.

Authors:  Ivy N Miller; Alice Cronin-Golomb
Journal:  Mov Disord       Date:  2010-12-15       Impact factor: 10.338

3.  Effects of under- and overcrowding on exploratory behavior in the elevated plus-maze.

Authors:  S Botelho; C Estanislau; S Morato
Journal:  Behav Processes       Date:  2007-01-04       Impact factor: 1.777

4.  Quantitative Analysis of Catecholamines in the Pink1 -/- Rat Model of Early-onset Parkinson's Disease.

Authors:  Cynthia A Kelm-Nelson; Michael A Trevino; Michelle R Ciucci
Journal:  Neuroscience       Date:  2018-02-27       Impact factor: 3.590

Review 5.  Cranial and related sensorimotor impairments in rodent models of Parkinson's disease.

Authors:  Sheila M Fleming; Tim Schallert; Michelle R Ciucci
Journal:  Behav Brain Res       Date:  2012-02-28       Impact factor: 3.332

6.  Sucrose self-administration and CNS activation in the rat.

Authors:  Dianne P Figlewicz; Jennifer L Bennett-Jay; Sepideh Kittleson; Alfred J Sipols; Aryana Zavosh
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-02-09       Impact factor: 3.619

Review 7.  Stages in the development of Parkinson's disease-related pathology.

Authors:  Heiko Braak; Estifanos Ghebremedhin; Udo Rüb; Hansjürgen Bratzke; Kelly Del Tredici
Journal:  Cell Tissue Res       Date:  2004-08-24       Impact factor: 5.249

8.  Characterization of 50-kHz ultrasonic vocalizations in male and female rats.

Authors:  Marilyn Y McGinnis; M Vakulenko
Journal:  Physiol Behav       Date:  2003-10

9.  For better or worse: The effect of levodopa on speech in Parkinson's disease.

Authors:  Aileen K Ho; John L Bradshaw; Robert Iansek
Journal:  Mov Disord       Date:  2008-03-15       Impact factor: 10.338

10.  Influence of prior maze experience on behaviour and response to diazepam in the elevated plus-maze and light/dark tests of anxiety in mice.

Authors:  R J Rodgers; J K Shepherd
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

View more
  7 in total

1.  Manipulation of vocal communication and anxiety through pharmacologic modulation of norepinephrine in the Pink1-/- rat model of Parkinson disease.

Authors:  Jesse D Hoffmeister; Cynthia A Kelm-Nelson; Michelle R Ciucci
Journal:  Behav Brain Res       Date:  2021-10-28       Impact factor: 3.332

2.  Psychological Stress Phenocopies Brain Mitochondrial Dysfunction and Motor Deficits as Observed in a Parkinsonian Rat Model.

Authors:  Mariana Grigoruţă; Alejandro Martínez-Martínez; Raul Y Dagda; Ruben K Dagda
Journal:  Mol Neurobiol       Date:  2019-12-14       Impact factor: 5.590

3.  Gene expression within the periaqueductal gray is linked to vocal behavior and early-onset parkinsonism in Pink1 knockout rats.

Authors:  Cynthia A Kelm-Nelson; Stephen Gammie
Journal:  BMC Genomics       Date:  2020-09-17       Impact factor: 3.969

4.  Predictors of prodromal Parkinson's disease in young adult Pink1-/- rats.

Authors:  Sarah A Lechner; Jacob M Welsch; Natalie K Pahapill; Taylor A R Kaldenberg; Amy Regenbaum; Cynthia A Kelm-Nelson
Journal:  Front Behav Neurosci       Date:  2022-09-12       Impact factor: 3.617

Review 5.  Rat Models of Vocal Deficits in Parkinson's Disease.

Authors:  Maryann N Krasko; Jesse D Hoffmeister; Nicole E Schaen-Heacock; Jacob M Welsch; Cynthia A Kelm-Nelson; Michelle R Ciucci
Journal:  Brain Sci       Date:  2021-07-13

6.  Intraperitoneal Administration of Forskolin Reverses Motor Symptoms and Loss of Midbrain Dopamine Neurons in PINK1 Knockout Rats.

Authors:  Emmanuel Vazquez-Mayorga; Mariana Grigoruta; Raul Dagda; Bridget Martinez; Ruben K Dagda
Journal:  J Parkinsons Dis       Date:  2022       Impact factor: 5.520

7.  Quantification of brainstem norepinephrine relative to vocal impairment and anxiety in the Pink1-/- rat model of Parkinson disease.

Authors:  Jesse D Hoffmeister; Cynthia A Kelm-Nelson; Michelle R Ciucci
Journal:  Behav Brain Res       Date:  2021-08-04       Impact factor: 3.352

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.